Safety and tolerability of oxcarbazepine in elderly patients with epilepsy.
Despite the high incidence of seizures and epilepsy in the elderly, the tolerability and safety of anticonvulsants are rarely evaluated in this patient population. We compared the safety and tolerability of oxcarbazepine in a cohort of 52 patients aged 65 years and older and a group of 1574 adult patients ranging in age between 18 and 64 years. There was no significant difference between the two groups with respect to premature discontinuation due to adverse events. The four most common adverse events experienced by patients in the elderly group, irrespective of their causal relationship to oxcarbazepine, were vomiting (19%), dizziness (17%), nausea (17%), and somnolence (15%). Three patients developed an asymptomatic hyponatremia, with at least one serum sodium level below 125mEq/L. Elderly patients on concomitant natriuretic drugs were significantly more likely to develop serum sodium levels below 135mEq/L. The results indicate that oxcarbazepine is safe to use in elderly patients and that its tolerability in this age group is similar to that of younger adult patients.
Kutluay
Ekrem
E
Department of Neurology, University of Michigan Health System, 1500 East Medical Center Drive, UH1B300/0036, Ann Arbor, MI 48109, USA.
McCague
Kevin
K
D'Souza
Joseph
J
Beydoun
Ahmad
A
D000293:Adolescent; D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D000927:Anticonvulsants / Q000009:adverse effects*; D002220:Carbamazepine / Q000009:adverse effects* / Q000031:analogs & derivatives*; D004361:Drug Tolerance; D004827:Epilepsy / Q000188:drug therapy* / Q000378:metabolism; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D000078330:Oxcarbazepine; D012964:Sodium / Q000378:metabolism
D000927:Anticonvulsants; D002220:Carbamazepine; D012964:Sodium; D000078330:Oxcarbazepine